Cardinal Health's Acquisition Of Zuellig Pharma Signal Of China's Intent To Allow More Foreign Investment?
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - In what some are calling a transformational event for the China pharma industry, Cardinal Health announced Nov. 29 that it has closed a deal to acquire local private distributor Zuellig Pharma China (Yong Yu in Chinese) for $470 million
You may also be interested in...
Three Years, Seven Acquisitions Later, Cardinal Health Has More Plans In China
U.S. distributor Cardinal Health goes full speed ahead in China. It has bought local players to tap into the regional market, doubled direct-to-patient pharmacies, and provided pharmacy management services to large hospitals among endeavors in the past three and a half years with more to come.
Three Years, 7 Acquisitions Later, Cardinal Health Has More Plans In China
U.S. distributor Cardinal Health goes full speed ahead in China. It has bought local players to tap into the regional market, doubled direct-to-patient pharmacies, and provided pharmacy management services to large hospitals among endeavors in the past three and a half years with more to come.
Cardinal Health Strives To Be A National Player In China Not Bound By Government Policy Goals
U.S. distributor Cardinal Health is doubling down in China and expanding its current network to become a national player.